Capsugel® DRcaps® capsules offer nutritional supplement makers a dosage form with outstanding consumer and manufacturing appeal. Some of the most common applications are for probiotics and enzymes. Pharmaceutical companies have also expressed interest in Capsugel® DRcaps® capsules for APIs which require some level of delayed release properties. Lonza developed a novel pharmaceutical modified-release technology named Vcaps® Enteric. Vcaps® Enteric are truly enteric and comply with the USP definition of enteric release.
Please note that Lonza has updated its Privacy Policy. By visiting our website or using services provided by Lonza, you are accepting the practices described in the Privacy Policy.
We also use cookies on our websites. Cookies allow us to give you the best browsing experience and help us to understand how you use our site. You can disable cookies but parts of our website may not work. Please read our updated Cookies Policy for information about which cookies we use and the information we collect. By continuing to use this website, you agree that we may store and access cookies on your device.
By clicking "I Agree", you confirm that you are above the age of 16, that you have read and understood the Privacy Policy and the Cookies Policy, and that you agree to the collection, use and processing of your Personal Information by Lonza in accordance with said policies.